As of June 2024 Amicus Therapeutics has a market cap of $2.90 Billion. This makes Amicus Therapeutics the world's 3539th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.90 B | -30.24% |
2023 | $4.16 B | 21.3% |
2022 | $3.43 B | 6.59% |
2021 | $3.21 B | -46.51% |
2020 | $6.01 B | 141.86% |
2019 | $2.48 B | 37.12% |
2018 | $1.81 B | -24.17% |
2017 | $2.39 B | 238.25% |
2016 | $0.70 B | -41.67% |
2015 | $1.21 B | 52.54% |
2014 | $0.79 B | 445.88% |
2013 | $0.14 B | 9.49% |
2012 | $0.13 B | 11.58% |
2011 | $0.11 B | -26.5% |
2010 | $0.16 B | 80.19% |
2009 | $90 M | -49.27% |
2008 | $0.17 B | -25.77% |
2007 | $0.23 B |
On Jun 1st, 2024 the market cap of Amicus Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Novo Nordisk NVO | $602.59 B | 20,659.60% | ๐ฉ๐ฐ Denmark |
Biogen BIIB | $32.75 B | 1,028.26% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $93.92 B | 3,135.67% | ๐ฌ๐ง UK |
Lexicon Pharmaceuticals
LXRX | $0.61 B | -78.83% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | $0.40 B | -85.90% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $14.25 B | 391.06% | ๐บ๐ธ USA |